HIGHLIGHTS
- who: Bruce J. Kirenga from the (UNIVERSITY) have published the research work: Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study, in the Journal: (JOURNAL) of 17/Nov/2022
- what: The main strength of this study is that the authors provide for the first time, to the knowledge , real-world data on the efficacy and tolerability of fluvoxamine among inpatients with COVID-19 in Africa.
SUMMARY
The SARS-CoV-2 pandemic has created a tremendous economic and health . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.